医疗保险优势和传统医疗保险中的心血管风险因素管理
Andrew S Oseran1,2, Rahul Aggarwal1,3, Rishi K Wadhera1,2,4
1Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, MA (A.S.O., R.A., R.K.W.).
Circulation. Cardiovascular quality and outcomes
|October 9, 2025
概括
医疗保险优势 (MA) 和传统医疗保险 (TM) 的受益者在管理心血管风险因素如高血压,糖尿病和高脂血症方面表现相似. 这项研究发现,MA和TM受试者之间的治疗或控制率没有显著差异.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 心血管疾病是医疗保险受益人死亡的主要原因.
- 可修改的心血管风险因素的管理仍然不够理想.
- 医疗保险优势 (MA) 注册人数正在增加,需要了解其护理质量.
研究的目的:
- 为了比较医疗保险优势 (MA) 和传统医疗保险 (TM) 受益人之间的心血管风险因素管理.
- 评估MA与TM入学者的高血压,糖尿病和高脂血症的治疗和控制率.
- 评估心血管风险因素在不断扩大的MA人口中的护理质量.
主要方法:
- 链接国家健康和营养检查调查 (2015-2018) 数据与医疗保险入学数据.
- 计算高血压,糖尿病和高脂血症的治疗和控制率的标准化年龄和性别差异.
- 使用国家健康和营养检查调查权重,用于65岁以上成年人的全国代表性估计.
主要成果:
- 分析了45,426,712名成年人 (34.4%的MA,65.6%的TM).
- 在MA和TM受益者之间,高血压,高脂血症或糖尿病的治疗率没有显著差异.
- 在MA和TM组中观察到类似的高血压,高脂血症和糖尿病的控制率.
结论:
- 对于关键心血管风险因素的治疗和控制率在MA和TM受益者之间是可比的.
- 尽管MA入学人数增加,但心血管风险因素管理的质量在MA和TM中似乎是一致的.
- 进一步的研究可能会探讨所有医疗保险受益人中低于最佳风险因素管理的原因.
相关概念视频
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:26Coronary Artery Disease IV: Preventive Measures
589
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
589
01:29Cardiomyopathy V: Interprofessional Care
338
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
01:23Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
01:30Heart Failure V: Medical Management
218
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
218
01:30Coronary Artery Disease I: Introduction
878
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878